Management of HBV in Liver Transplant Patients


The Post-Transplant Challenge: How to Prevent HBV Recurrence Keeping Sight of HDV Co-infection, Hepatocellular Carcinoma and Other Risk Factors

Thursday, December 16, 2021, 10:00 AM (Local time in Montreal)
Local time (Corresponding local time at your current location)

Overview

This will include clinical cases as examples, including details of when best to use hepatitis B immunoglobulin, when to use antiviral therapy, when to use screening testing and how to best interpret.

Learning Objectives

  1. Framework for HBV management in SOT
  2. When to test for HDV
  3. What to do with positive results
  4. How to best screen for HCC
Moderator
Manuel Rodriguez-Davalos
USA
Bio
Speaker
Emily Bethea
USA
Bio
Speaker
Patrizia Burra
Italy
Bio

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada